---
title: "Top 10 US Stock Losers (2.27)"
description: "Avidity Biosciences(RNA) fell 79.74%, with a trading turnover 122.7 Million USD, and a year-to-date fell 79.6%. Sunrun(RUN) fell 35.11%, with a trading turnover 772.8 Million USD, and a year-to-date f"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/277253681.md"
published_at: "2026-02-27T22:00:51.000Z"
---

# Top 10 US Stock Losers (2.27)

> Avidity Biosciences(RNA) fell 79.74%, with a trading turnover 122.7 Million USD, and a year-to-date fell 79.6%. Sunrun(RUN) fell 35.11%, with a trading turnover 772.8 Million USD, and a year-to-date fell 28%. PAR Tech(PAR) fell 27.03%, with a trading turnover 102.5 Million USD, and a year-to-date fell 54.8%.

NASDAQ Composite Index has fell 0.92%, with a year-to-date fell 2.5%; S&P 500 has fell 0.43%, with a year-to-date rose 0.5%; Dow Jones Industrial Average has fell 1.05%, with a year-to-date rose 1.9%.

Avidity Biosciences(RNA) fell 79.74%, with a trading turnover 122.7 Million USD, and a year-to-date fell 79.6%.

Sunrun(RUN) fell 35.11%, with a trading turnover 772.8 Million USD, and a year-to-date fell 28%.

PAR Tech(PAR) fell 27.03%, with a trading turnover 102.5 Million USD, and a year-to-date fell 54.8%.

### Related Stocks

- [RNA.US - Avidity Biosciences](https://longbridge.com/en/quote/RNA.US.md)
- [RUN.US - Sunrun](https://longbridge.com/en/quote/RUN.US.md)
- [PAR.US - PAR Tech](https://longbridge.com/en/quote/PAR.US.md)
- [FIGR.US - Figure Tech Solutions - CL](https://longbridge.com/en/quote/FIGR.US.md)
- [WLDN.US - Willdan](https://longbridge.com/en/quote/WLDN.US.md)
- [PCT.US - PureCycle Tech](https://longbridge.com/en/quote/PCT.US.md)
- [PGNY.US - Progyny](https://longbridge.com/en/quote/PGNY.US.md)
- [CRI.US - Carters](https://longbridge.com/en/quote/CRI.US.md)
- [BFLY.US - Butterfly Network](https://longbridge.com/en/quote/BFLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| PAR 科技｜8-K：2025 財年 Q4 營收 1.2 億美元超過預期 |  | [Link](https://longbridge.com/en/news/277098050.md) |
| Carters 第四季度利潤超出預期，銷售額增長了 8% | Carter's 報告第四季度利潤超出預期，淨銷售額同比增長 8%，達到 9.25 億美元。第四季度調整後每股收益為 1.76 美元，超過分析師預期的 1.74 美元。在 2025 財年，淨銷售額同比增長 2%，而 2026 財年的展望預計 | [Link](https://longbridge.com/en/news/277188017.md) |
| Progyny｜10-K：2025 財年營收 12.89 億美元超過預期 |  | [Link](https://longbridge.com/en/news/277213481.md) |
| 華爾街頂級預測師在第四季度財報發佈前重新調整了對 Carters 的預期 | Carter’s, Inc.（紐約證券交易所代碼：CRI）將於 2 月 27 日發佈其第四季度財報，分析師預測每股收益為 1.70 美元，低於去年的 2.39 美元。預計收入將達到 9.2287 億美元，高於去年的 8.5971 億美元。初 | [Link](https://longbridge.com/en/news/277160104.md) |
| Butterfly Network｜8-K：2025 財年 Q4 營收 31.51 百萬美元超過預期 |  | [Link](https://longbridge.com/en/news/277035563.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.